课题基金 / 基金详情

Analysis of suscebility genes and pathogenesis of HTLV-I-associated Sjogren's syndrome

Analysis of suscebility genes and pathogenesis of HTLV-I-associated Sjogren's syndrome
HTLV-I相关干燥综合征易感基因及发病机制分析
批准号:
13557042
负责人:
EGUCHI Katsumi
金额:
$6.46万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

EGUCHI Katsumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
HTLV-I has been identified as a causative agent which initiates and/or perpetuates the process of Sjogren's syndrome (SS). A high seroprevalence of HTLV-I infection has been determined in SS patients in the HTLV I-endemic area of Nagasaki, Japan. Many patients with HTLV-I-associated myelopathy (HAM/TSP) have been complicated with SS. The present study was undertaken to clarify the involvement of HTLV-I infection on the development or perpetuation of SS. At first, we analyzed promoter region polymorphisms of the IL-10 gene. Our results suggest that the presence of the ATA haplotype of the IL-10 gene are associated with an increased susceptibility to primary SS. Moreover, IL-10 gene promoter region polymorphism affects the age at onset of SS, and the amounts of serum IgG. However, there is no association between the presence of anti-HTLV-I antibodies and IL-10 gene polymorphism. Next, two-color analysis by flow cytometry revealed a significantly high percentage of IL-12Rβl^+ cells in CD4 … More ^+T lymphocytes in HAM/TSP patients compared to the control. These results suggest Th1 immune activation in patients with HAM/TSP, which leads to chronic inflammation in the tissues, mediated by dysregulation of the IL-12/IL-12R. Furthermore, the sLe^<x+>+ cell population, which has features of activated Th1 cells with up-regulated expression of E-selectin and P-selectin ligands mediated by HTLV I infection, is increased in peripheral blood CD4^+T lymphocytes in HAM/TSP patients. These findings suggest their involvement in transmigration of T lymphocytes from peripheral blood into tissues. In addition, our results indicate that peripheral blood CD4^+T lymphocytes of HAM/TSP patients are resistant to apoptosis triggered through mitochondrial death pathway through up-regulations of expression of anti-apoptotic protein, Bcl-xL. We used HTLV-I tax transfectants to show that tax-mediated induction of Bcl-xL expression can protect cells from apoptotic stimuli in a mitochondria-dependent fashion. Compared with tax-negative JPX-9 cells, Bcl-xL expression was clearly augmented in tax-positive JPX-9 cells. These cells were resistant to both receptor-mediated apoptosis and chemical induced apoptosis. Theses results suggest that tax-mediated Bcl-xL expression inhibit apoptosis of activated T lymphocytes in HTLV-I-seropositive subjects, which consequently promotes the onset of autoimmune disorders such as SS. Finally, we demonstrated the expression of TLR-2, TLR-3 and TLR4 on the acinal and ductal cells, and infiltrated mononuclear cells from minor salivary glands of SS. When a human salivary glands (HSG) cell line were stimulated by peptidoglycan, poly I : C, or LPS, HSG cell line augmented the expression of CD54 and production of IL-6, through the phosphorylation of MAP kinase. From the above findings, the development and/or perpetuation of SS might be implicated with HTLV-I infection and the susceptibility genes. Less
期刊论文(359)
专著(0)
科研奖励(0)
会议论文
Eguchi K.: "Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis."Intern Med. 41. 77-78 (2002)
Eguchi K.:“系统性红斑狼疮并发巨细胞病毒诱导的噬血细胞综合征和结肠炎。”实习医学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawakami A, et al.: "Role of HTLV-I infection in the pathogenesis of Sjogren's syndrome and rheumatoid arthritis."Mod Rheumatol. 11. 87-90 (2001)
Kawakami A 等人:“HTLV-I 感染在干燥综合征和类风湿性关节炎发病机制中的作用。”Mod Rheumatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ida H: "Granzyme B leakage-induced cell death: a new type of activation -induced natural killer cell death"J Immunol. (accepted).
Ida H:“颗粒酶 B 渗漏诱导的细胞死亡:一种新型的激活诱导的自然杀伤细胞死亡”J Nutrition。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yanagi K: "Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo"Int J Oncol. 22. 345-351 (2003)
Yanagi K:“用表达 fms 样酪氨酸激酶 3 配体和 CD40 配体的腺病毒对体内小鼠肝癌细胞进行免疫基因治疗”Int J Oncol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
155
    Role of innate immunity on initiation of autoimmune diseases and its regulation
    • 批准号:
      15390316
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.96万
    • 财政年份:
      2003
    • 负责人:
      EGUCHI Katsumi
    • 依托单位:
    Mechanisms of immunoregulation by serine proteinase inhibitor and its application of therapy for rheumatic disease
    • 批准号:
      13670461
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.62万
    • 财政年份:
      2001
    • 负责人:
      EGUCHI Katsumi
    • 依托单位:
    Role of Fas mediated apoptosis in the process of autoimmune thyroid diseases : possible involvement of Fas ligand (FasL) expression in breakdown of "immunoprevileged site" formation
    • 批准号:
      11671091
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      1999
    • 负责人:
      EGUCHI Katsumi
    • 依托单位:
    Role of HTLV-I on pathegenesis of Sjogren's syndrome
    • 批准号:
      09670482
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1997
    • 负责人:
      EGUCHI Katsumi
    • 依托单位:
    国内基金
    海外基金
    草鱼NF-κB p50与IL-10启动子的结合特性及其调控效应
    IL-10通过STAT3磷酸化编码调控椎间盘退变中“保护-病理”双重效应的机制研究
    • 批准号:
      2026JJ82659
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      汤亮
    • 依托单位:
    IL-10和PD-1双通路对乙肝表面抗原滴度快速下降的影响及其对乙肝临床治愈率的预测价值研究
    • 批准号:
      JCZRLH202600212
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: